The Role of Antinuclear Antibody in Predicting the Efficacy and Immune-Related Adverse Events of Immunochemotherapy in Esophageal Squamous Cell Carcinoma: A Real-World Analysis.
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.